Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2006/041266external-prioritypatent/WO2007053346A1/en
Application filed by Lilly Co ElifiledCriticalLilly Co Eli
Publication of TNSN08190A1publicationCriticalpatent/TNSN08190A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Plural Heterocyclic Compounds
(AREA)
Abstract
The present invention provides kinase inhibitors of Formula (I) wherein R1, R2, and X are as described herein, or a pharmaceutically acceptable salt thereof. The compounds act as inhibitors of the p38 kinase and are useful for the treatment of conditions resulting from excessive cytokine production
TNP2008000190A2005-10-282008-04-25Pyrazole-isoquinoline urea derivatives as p38 kinase inhibitors
TNSN08190A1
(en)